Mantle cell lymphoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:
{{ Mantle cell lymphoma }}
{{ Mantle cell lymphoma }}


{{CMG}}
{{CMG}}; {{AE}} {{AS}}
 
==Overview==
==Overview==
Mantle cell lymphoma is a rare disease that tends to affect elderly patients > 60 years. Male are more commonly affected with mantle cell lymphoma than female. The male to female ratio is approximately 4 to 1.
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
the incidence of mantle cell lymphoma was estimated to be 3-10% of non-hodgkins lymphoma.
===Prevalence===
===Prevalence===
There are only about 15,000 patients presently in the U.S. (The prevalence seems to be somewhat higher in Europe.)  
There are only about 15,000 patients presently in the U.S. (The prevalence seems to be somewhat higher in Europe.)  
===Age===  
===Age===  
At diagnosis, the typical patient is in their 60s and usually presents to the oncologist with advanced disease.
Mantle cell lymphoma is a rare disease that tends to affect elderly patients > 60 years.  
===Gender===
===Gender===
The ratio of males to females affected is about 4:1.
Male are more commonly affected with mantle cell lymphoma than female. The male to female ratio is approximately 4 to 1.
   
   
==References==
==References==

Revision as of 18:57, 31 August 2015

Mantle cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mantle cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mantle cell lymphoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mantle cell lymphoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mantle cell lymphoma epidemiology and demographics

on Mantle cell lymphoma epidemiology and demographics

Mantle cell lymphoma epidemiology and demographics in the news

Blogs on Mantle cell lymphoma epidemiology and demographics

Directions to Hospitals Treating Mantle cell lymphoma

Risk calculators and risk factors for Mantle cell lymphoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

Mantle cell lymphoma is a rare disease that tends to affect elderly patients > 60 years. Male are more commonly affected with mantle cell lymphoma than female. The male to female ratio is approximately 4 to 1.

Epidemiology and Demographics

Incidence

the incidence of mantle cell lymphoma was estimated to be 3-10% of non-hodgkins lymphoma.

Prevalence

There are only about 15,000 patients presently in the U.S. (The prevalence seems to be somewhat higher in Europe.)

Age

Mantle cell lymphoma is a rare disease that tends to affect elderly patients > 60 years.

Gender

Male are more commonly affected with mantle cell lymphoma than female. The male to female ratio is approximately 4 to 1.

References

Template:Hematology

Template:WH Template:WS